$0.5090
0.02414.97%
Last update: Nov 11, 5:23 PM
Scinai Immunotherapeutics Ltd
SCNINASDAQ
Scinai Immunotherapeutics fell 95.3% from $10.90 to $0.51, behind the S&P 500's +11.2%. Its worst day was Sep 15 (−36.9%), and its low came Nov 6 at $0.44.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Scinai Immunotherapeutics closed at its highest level of the year, 14.7% above where the year started.
+1.6% · S&P 500 +0.2%
EPS of $-35.60 was reported on $1.3M revenue.
Story events cover the past 12 months · Times ET
+15.7% · S&P 500 +0.8%
Scinai Immunotherapeutics shares rose 61.6%, while the S&P 500 rose 0.8%.
+61.6%, the year's best day · S&P 500 +0.8%
EPS of $-6.40 was reported on $949,000.00 revenue.
−2.8% · S&P 500 −0.3%
Scinai Immunotherapeutics shares rose 47.0%, while the S&P 500 fell 0.4%.
+47.0% · S&P 500 −0.4%
Scinai Immunotherapeutics shares fell 28.5%, while the S&P 500 fell 1.1%.
−28.5% · S&P 500 −1.1%
Scinai Immunotherapeutics closed at its lowest level of the year, 96.0% below where the year started.
−2.2% · S&P 500 +0.3%
Where it ended: a close of $0.51 on Nov 11, 2026.
Nothing in the past 12 months.
All SCNI analyst actionsNothing in the past 12 months.
All SCNI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SCNI and SPY from Benzinga historical bars. Not investment advice.
